Mr. Cochrane obtained his bachelor’s degree in Biology and Biochemistry from the University of Winnipeg in 1998. Following a brief career in environmental testing, Mr. Cochrane joined Cangene Corporation as a Quality Control Analyst where he learned the basics of GMP and biopharmaceutical development and manufacturing principals. In 2001 Mr. Cochrane was promoted to Analytical Validation Supervisor where he was responsible for forming a team and supervising validation specialists deployed for the support of analytical method and equipment validation. Mr. Cochrane was recruited to KS Avicenna, Inc. in Edmonton, Alberta in 2002 as the site Quality Assurance Manager where he was responsible for all aspects of quality and compliance for the site including operational management of the QA team and hosting corporate and regulatory inspections. In 2003 he was seconded into the Quality Control department at KS Avicenna, Inc. as Manager where he became responsible for guiding the group through an organization restructuring. Following the acquisition of the KSA site by QSV Biologics, Ltd in 2004 he was promoted to the position of Manager, Projects and Process Development, and further promoted to Director of Project Operations in 2008, where he successfully established a world-class process development team and associated project management philosophies and principals that allowed QSV to become a mid-tiered CMO over the course of five years. Following closure of QSV in 2009, Mr. Cochrane was recruited to Therapure BioPharma, Inc. in Mississauga, Ontario in the position of Director Office of Project and Process Management. With over fourteen years of life science industry experience and over ten years progressive management experience in biopharmaceutical GMP development and manufacturing, Mr. Cochrane provides a breadth of experience in the biologics industry in Quality Control, Quality Assurance, Validation, Operations, Development, Project Management and Business Development.